NEO

#2441
NeoGenomics, Inc.
8.35 USD
+2.33%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
8.35
8.36
Faixa anual
4.72
13.74
Mudança diária
+2.33%
Mudança mensal
+2.33%
Mudança em 6 meses
-19.25%
Mudança anual
-10.98%
Fechamento anterior
8.16
Abrir
8.36
Bid
Ask
Mínimo
8.35
High
8.36
Volume
292
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.08 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Diagnósticos e pesquisa
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-14
Índice preço/fluxo de caixa
2.07

NeoGenomics Inc

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

Notícias